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ABSTRACT

Throughout your lifetime renewable tissues and those which are exposed to prolonged
inflammation experience an accumulation of senescent cells. These cells have previously been
shown to acquire the senescence-associated secretory phenotype (SASP) that promotes
proliferation and tumorigenesis of epithelial cells, thus increasing the invasive ability of tumor
cells (1). SASP is characterized by an upregulation in mRNA levels of a number of secretory
factors, such as growth factors, cytokines, and chemokines. It has been shown that lifetime
exposure to oxidative stress can influence cell cytoskeleton reorganization and influence aging
processes (2). In addition matrix metalloproteinases are key SASP factors that degrade the
extracellular matrix (ECM), accompanying the aging process and are in part regulated by the
production of reactive oxygen species (ROS) (2). We sought to first determine if SASP factors
modulate the invasive properties of tumor cells as previously reported and if this process is
redox-dependent. In addition, we questioned whether efficient antioxidant compounds, such as
apple peel extract (APE) derived from Gala apples, that have been previously shown to contain
several classes of polyphenolic antioxidants could modulate invasion and SASP. We have shown
that both the invasive and migratory properties of metastatic mammary tumor cells (MDAMB231) can be prevented by treatment with the nutritional antioxidant, APE. Furthermore, we
have established that the SASP-dependent regulation of tumor migration and invasion is
impaired by treatment with APE. Overall, by gaining an understanding of the SASP by
manipulating tumor invasion and also identifying key factors that are upregulated, future studies
may reveal the interplay of molecular mechanisms of SASP, with the long-term goal of finding
natural or synthetic therapies that can control the deleterious effects of this phenotype.
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1.1 Aims of studying the Senescence Associated-Secretory Phenotype (SASP) and Invasion
As organisms age there is a correlated increase in the risk of developing a plethora of
diseases, including several forms of cancer. Recent studies have revealed that the process of
aging is a key component for the development of aberrant phenotypes during later stages of life.
(1). However, in order to assess what age-related conditions, such as the tumor
microenvironment (TME), are responsible for the onset of chronic diseases it is first important to
understand the characteristic features of cells with limited proliferative capabilities. The aging
cell undergoes similar physiological changes as do cancer cells due to the presence of reactive
oxygen species (ROS), which enable both aging and cancer cells to alter their basal cellular
interactions, promoting the development of age-associated disease and invasion of secondary
tissues, or metastasis, respectively.
1.2 Background of SASP and Redox-Dependent Invasion of Metastatic Cancer Cells
Cells undergoing cellular stress, such as DNA damage, and irradiation often initiate a
crucial tumor-suppressor mechanism called programmed cell death, or apoptosis. Alternately,
when cells respond to stress and halt their progression through the cell division cycle, they
undergo the process known as replicative or cellular senescence (3). Unlike quiescent cells,
which arrest in the G0 stage of the cell cycle and are capable of resuming proliferation in
response to appropriate signals, senescent cells notably remain metabolically active at G1 phase
and lack the capacity to initiate proliferation even in response to stimuli (4). The process of aging
entails an accumulation of senescent cells through mechanisms that resist apoptosis, and it is not
quite clear how cells determine whether to undergo the apoptotic pathway or cellular senescence
(4).
Cellular senescence is induced in order to prevent cancer-prone cells from initiating
tumorigenesis, and as such, it is recognized as a cell-autonomous tumor suppressive mechanism
(1). However, during later stages of life cellular senescence has been suggested to contribute to
the development of age-related diseases, and therefore, acts in both beneficial and deleterious
manners. This phenomenon can be explained by the evolutionary theory known as antagonistic
pleiotropy, which recognizes that fitness-promoting processes that are beneficial for an organism
early in life may have deleterious effects at later stages of life (3). That is, since there are fewer
aged members of the population and reproduction occurs early in life, the selective pressures of
natural selection are not strong enough to improve the detrimental phenotypes that occur at later
ages.
Recent research has identified changes in gene expression that are associated with
senescence growth arrest. These include an increase in the mRNA levels and secretion of several
growth factors, cytokines, and chemokines that together are referred to as the senescenceassociated secretory phenotype (SASP) (5). By assessing whether the SASP can promote the
invasive abilities of metastatic cancer cells, further studies can identify the mechanisms by which
these specific factors can induce tumorigenesis. Invasion of tumor cells through basement
membranes is thought to be an essential phase in the successful formation of tumors and their
further metastatic abilities as they development into secondary malignant growths at distant sites.
Basement membranes are extracellular matrices (ECMs) that are made of several molecules,
such as specific collagens, laminins, and proteoglycans (6).
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In order for epithelial cells to become invasive and metastasize, they must go through a
series of steps, which begins with the loss of the cell’s polarity and detachment from the
surrounding cells in the primary tissue. Then the tumor cell attaches to the matrix through
increased integrin connections with the underlying ECM, and various proteases degrade the
protein interactions that hold the matrix together, enabling the tumor cell to move throughout the
matrix toward blood and lymphatic vessels (7). As tumor cells begin to invade lymphatic or
vascular beds they cross the basement membrane and loose epithelial cell characteristics, in a
process called epithelial to mesenchymal transition (EMT), which is characterized by a downregulation of E-cadherin, a molecule important for maintaining cell-to-cell adhesions (7). After
the tumor cell becomes angiogenic and undergoes the EMT it can penetrate other membranes
and colonize distant organ tissues to form secondary tumors.
In addition to tumor cells having the ability to promote EMT, when senescent
fibroblasts acquire the SASP these cells become pro-inflammatory and can enhance tumor
progression by inducing EMT (8) Both the release of soluble signaling factors, such as
interleukins, cytokines, and growth factors, as well as secreted proteases, facilitate the disruption
of epithelial organization and progression of pre-malignant or malignant epithelial cells by
senescent cells. It has been shown that the secretion of high levels of IL-6 and IL-8 by senescent
cells in breast cancer enhances the invasive capacity of this cancer cell line in cell culture.
Additionally, conditioned media from senescent cells contains low levels of cell surface ßcatenin and E-cadherin, which is consistent with EMT and thus, the mechanisms tumor cells
leave the primary tumor and invade surrounding tissue (8).
The involvement of ROS and the redox dependency of several key factors that promote
ECM turnover has become a growing area of research because the metastatic process has been
identified to act as a cell death escape mechanism (7). That is, redox pathways that result in cell
proliferation, cell motility/invasion, and glycloysis, evolved to rescue cells from oxidative
stresses, as well as inflammation and immune attacks (7). Recently, these redox switches have
been shown to be incorporated with ligand-dependent cascades of growth factors and ECM
proteinases, such as MMP-1, that further promote metastatic activity (2). Therefore, by further
investigating the redox-dependent roles of factors like MMP-1 it may be possible to develop
therapies that can inhibit or lessen the deleterious activity that accompanies senescenceassociated oxidative stress (9).
Manganese superoxide dismutase (Sod2), a eukaryotic enzyme that catalyzes the
dismutation of superoxide into hydrogen peroxide (H2O2) and oxygen (O2) in the mitochondria
of cells has previously been defined as having tumor suppressor function because of its low level
expression in many tumor types (10). Recently it was shown that loss of Sod2 expression is
likely an early event in tumor progression that further results in a tumorigenic phenotype due to
steady state increases in free radicals by Sod2 (11). Sod2 overexpression promotes the metastatic
phenotype by producing H2O2, in the mitochondria, but if there is efficient scavenging of H2O2
this malignant phenotype can be reversed. By using Sod2 to modulate the cellular redoxenvironment the characterization of redox-dependent signaling events that drive malignancy such
as, invasion and migration, can be accomplished. In the future, detailed studies of redoxdependent events will enable researchers to develop targeted therapeutic interventions that can
efficiently inhibit the redox-signaling mechanisms that are essential for metastatic progression.
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Figure 1.2a SASP-Driven Epithelial-Mesenchymal Transition (EMT) to Initiate
Metastasis. (a) A senescent fibroblast in a tumor microenvironment (TME) secretes various
factors to stimulate epithelial cell proliferation. (b) Then the SASP-containing many factors
(e.g., interleukins, matrix metalloproteinases (MMP) and chemokines) stimulates
transformed cells to undergo the EMT. (c) Finally, the SASP promotes the migration,
invasion and metastasis of mesenchymal-like cells.
1.3 Apple Peel Extract (APE) as a natural antioxidant and potential novel drug therapy
The age-old saying “an apple a day keeps the doctor away” has prompted researchers to
further understand the inverse relationship between consumption of apples and the risk of
developing some cancers. The phytochemicals, or compounds derived from fruits and
vegetables, which constitute the peel of an apple have been shown to contain many classes of
polyphenolic antioxidants (12). Only a limited number of studies have evaluated the health
benefits of apple peels. However, it has been shown that strong antioxidants that make up apple
peels, such as quercetin and catechin, reduce cancer cell proliferation and therefore, contribute to
apple’s anticancer activity. One study examined cellular responses in different cancer cell lines
treated with APE (derived from Organic Gala apples) using immmunoblot analysis to examine
PCNA, proliferative cell nuclear antigen, a biomarker for elevated proliferation indexes
indicative of both breast and prostate cancer. Decreased PCNA activity resulted from APE
treatment (5% and 2.5%) and this is consistent with the significant G0-G1 phase cell cycle arrest
identified in response to APE using a cell cycle distribution assay (12).
We aim is to show that our freeze-dried method of APE preparation will preserve the
inhibitory effects of the antioxidants constituting APE and effectively reduce migration in
various cell types. In addition, we will examine changes in MMP-1 expression in APE-treated
HT1080 fibrosarcoma cells and utilize APE treatment to observe how migration of MDAMB231 metastatic breast cancer cells is altered as a result of this potent antioxidant treatment.
Further studies, using in vivo animal models to understand the molecular mechanisms by which
APE acts as an antioxidant and potential antiproliferative treatment must be performed before
APE can be adapted as a novel cancer or age-related disease therapy.
Materials and Methods
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2.1 Cells lines, media, and growing conditions
MDA-MB231, primary human breast adenocarcinomas, were cultured in DMEM with
sodium pyruvate supplemented with 10% FBS, 1,000 U/mL penicillin, and 500 g/mL
streptomycin (ATCC). IMR-90, primary human fetal lung fibroblasts were obtained from ATCC
and cultured in MEM supplemented with 10% FBS, 1,000 U/mL penicillin, 500 g/mL
streptomycin, and amphotericin (ATCC). HT1080, derived from a human fibrosarcoma and
obtained from ATCC were cultured in DMEM supplemented with 10% fetal bovine serum
(FBS), 1,000 U/mL penicillin, 500 g/mL streptomycin, and G418 antibiotic. HT1080 cells were
engineered as follows: the CMV line had no vector transfected, an Sod2-increasing activity
vector was transfected into HT1080 cells, giving the Sod2 cell line, and the Sod2 vecto, as well
as a catalase vector, were transfected into HT1080 cells to give Sodcat cells that were grown
with an additional zeocin antibiotic.
Cell Growth
Cell lines were grown in standard cell culture conditions (37C, 5% CO2 in a
humidified incubator) and were passaged two or three times a week to maintain them at
subconfluent levels, depending on the cell line and confluency. Stable cell lines were generated
for each cell line.
2.2 Preparation of cDNA and RT-PCR analysis of SASP factors
Cells to CT Kit (Invitrogen)
The number of cells for each individual cell line (IMR90, both presenescent p<15 and
senescent p>25, CMV, Sod2, and Sodcat) was counted and 8x103 cells/mL were seeded into a 96
well plate. Cultured medium from wells was aspirated and 50 µL of cold (4C) 1X PBS was
added to each well. PBS was aspirated and 50 µL Lysis Solution was added to each sample and
each reaction was thoroughly mixed. The lysis reaction was incubated for 5 min at room
temperature (19-25C). 5 µL Stop solution was added to each lysis reaction and incubated at
room temperature for 2 min. RT Master Mix was assembled using 2X SYBR RT Buffer (25
µL/reaction), 20X RT enzyme Mix (2.5 µL/reaction), and Nuclease-free water (12.5
µL/reaction). 40 µL RT Master Mix and sample lysate (10 µL) were added to nuclease-free PCR
tubes. A thermal cycler set at 37˚C for 60 min, then at 95C for 5 min to denature the resulting
cDNA.
Real Time Polymerase Chain Reaction (RT-PCR)
One tube of PCR cocktail was assembled for each gene of interest (MMP-1,IL-1, IL-8,
MCP-1, MCP-2, GMSCF, Gro, IGF-7).The PCR cocktail consists of Power SYBR Green
PCR Master Mix (10 µL/reaction), Forward and Reverse PCR Primers (2 µL/reaction at 10 nM)
determined using Vector NTI, and nuclease-free water (2 µL/reaction).16 µL of PCR cocktail
was added to 4 µL of cDNA sample. Three independent replicates were run in triplicate and βactin was used as the endogenous control. The plate was centrifuged for a short spin and the
reaction was run using the Stepone Plus Real-Time PCR system (Applied Biosystem). The
reaction was repeated for 35 cycles at 95C (20 sec) with a final extension at 60C (20 sec). The
∆∆Ct method was followed per the manufacturer’s instructions in order to calculate fold-changes
in expression of each target with respect to the β-actin control (Applied Biosystems).
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Agarose gel electrophoresis
40 mL of ddH2O and 0.4 g of agarose were microwaved for 40 sec to make a 1% agarose
gel solution. 1.5 µL of ethidium bromide was added and the chamber was set up by inserting a
10-well comb at the negative terminal. The solution was poured in and left to polymerize for 15
min. 10 µL of the 300bp-1kb exACTGene DNA ladder (Fischer) was loaded into the first well
and the PCR products were loaded in adjacent wells from a 10 µL mix of sample and loading
dye (1:1). The gel was run at 1000V for 35 min and visualized with the Alpha Imager under a
UV filter.
2.3 Derivation of Apple Peel Extract (APE)
Organic (6 lbs) Gala apples were obtained and the peels were removed in a hypoxic
tissue culture hood and placed in a sterile freeze dry container. Nitrogen gas was sprayed on the
peels and in a lyophilizer (Labconco) the peels were freeze-dried at -82C for 48 hr. The frozen
apple peels were homogenized and apple peel extract (APE) used for treatment was made with
1g APE powder suspended in 10 mL basal cell culture media (10% APE). The solution was
centrifuged at 5000 x g for 5 min and the supernatant was removed. This was repeated three
times and the final supernatant was filter sterilized in a 0.22 µm filter (Corning), aliquoted, and
stored at -20C.
2.4 In Vitro Matrigel Invasion Assay
The Matrigel Invasion Chamber package (BD Biocat) was brought to room temperature.
0.5 mL of serum free media (37 ˚C) was applied to the interior of the inserts and bottom of wells.
The inserts were left to rehydrate for 2 hr in a tissue culture incubator, at 37C, 5% CO2. 0.75
mL of IMR90 presenescent (p<15) and senescent (p>15) conditioned media was added to the
bottom of the insert. Then 0.5 mL of MDA-MB231 cell suspension (2.5x104 cells/mL) was
added to the interior of the insert. The chambers were incubated for 24 hr in a humidified tissue
culture incubator (37C, 5% CO2). A cotton-tipped swab was used to remove non-invading cells
by applying gentle pressure across the membrane surface. Media was then aspirated and 0.5 mL
of serum-free media was added to each well. A second repeat of swabbing was performed. 0.5
mL of cold methanol (4C) was added to the wells adjacent to the inserts. The inserts were
transferred into those methanol-containing wells and 0.5 mL of methanol (4C) was applied to
the top of the inserts. Cells were fixed for 15 min at -20C and then the inserts were left to dry in
at room temperature in a tissue culture hood for 15 min. Insert membranes were cut out with a
razor and mounted on glass slides with DAPI mounting media (Invitrogen). Slides were left to sit
in the dark for 15 min and then visualized using QCapture under a UV filter. The number of cells
was counted using the freeware, ImageJ, and the ratio of presenescent cells to senescent cells
was calculated. Statistical analysis was performed using Tukey’s Student T-test.
2.5 Wound Healing Assay
19 x 104 cells/mL (MDA-MB231, CMV, Sod2 and Sodcat cell lines) were plated in a 24well plate and cells were allowed to reach 80% confluency overnight. Wounding across each
well was performed using a 10 µL pipette. Cells were then treated with 500 µL of 0% APE
(culture media), 0.3% APE, 1% APE, and 3% APE in triplicate. Images of the wound distances
were taken in triplicates at a designated area (drawn with a marker across the bottom of the plate)
directly after treatment and again after 16-18 hr of treatment. Wound distances were measured
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using the freeware, ImageJ, and the difference between the wound distance directly after
treatment and after 16-18 hr of treatment was calculated. The calculated difference is the
respective wound closure and the percentage of wound closure was calculated by dividing the
average wound closure of APE-treated cells by the wound closure of untreated cells and
multiplying by 100. Statistical analysis for the MDA-MB231 cell line was performed using
Tukey’s Student T-test and statistical analysis was performed using one-way ANOVA for the
CMV, Sod2, and Sodcat cell lines.

2.6 Crystal Violet Cytoxicity Assay
MDA-MB231 cells were plated at a density of 8,000 cells/well in a 96-well plate,
allowed to attach overnight (24 hr), and then treated with 3% APE in a 1:3 serial dilution in
triplicates. Control wells were not treated with APE and fresh vehicle control media was given to
them. At this time point media was removed and 50 µL of crystal violet stain was distributed to
the control wells and allowed to sit at room temperature for 10 min. The 96-well plate was rinsed
in a water bath to remove excess crystal violet stain. Absorbance readings at 570 nm were taken
using a plate reader (Tecan). After 24 hr of treatment, staining and absorbance reading were
repeated for both control- and APE-treated cells. Statistical analysis was performed using oneway ANOVA.

RESULTS
One characteristic of many age-related degenerative diseases is enhanced extracellular
matrix (ECM) breakdown, which is accompanied by the presence of reactive oxygen species
(ROS) and their subsequent activation of upstream kinase cascades. Matrix metalloproteinase-1
(MMP-1) has been found to be a major regulator for maintaining ECM turnover and the
expression of MMP-1 is highly sensitive to the cellular redox state (9). In an effort to determine
the effects of antioxidant therapy on redox-dependent expression of MMP-1 apple peel extract
(APE) treatment was performed on the engineered HT1080 cell lines.
It has been previously shown that cytotoxicity assays using APE from a freeze-drying
method have used concentrations up to 5% APE after compound analysis determined the high
concentration of polyphenolic antioxidants (12). By peeling the apples in a hypoxic chamber (1%
O2) and then freeze-drying the peels, I aimed to preserve the antioxidant capacity of the APE
treatment and therefore, a maximum concentration of 3% of the lyophilized extracts was used for
treatment.
RT-PCR analysis with cDNA from control no vector (CMV) cells, mitochondrial
superoxide dismutase (Sod2) over-expressing cells (Sod2), and Sod2 over-expressing cells also
expressing catalase (Sodcat) was performed in order to measure mRNA expression of MMP-1.
cDNA was then derived from these three cell lines after a 24 hr treatment with 3% APE and RTPCR analysis was performed to observe fold changes in MMP-1 mRNA levels due to the
antioxidant treatment. In the cells not treated wth APE there was an observed sixty-fold increase
in MMP-1 expression in the Sod2 cell line compared to CMV cells supporting previous studies
that found that H2O2 generated by Sod2 is required for induction of MMP-1. In addition, the
increase in Sodcat cells have a higher level of MMP-1 expression, but because of the catalase
vector these cells at a lower cellular redox state. Treatment with 3% APE lead to a significant
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decrease in MMP-1 expression in both Sod2 and Sodcat cells (Fig. 3.1a), which is consist with
the redox-dependent role of MMP-1 expression.
3.1 RT-PCR data analysis

Figure 3.1a: mRNA expression of MMP-1 is lower in Sod2, and Sodcat cell lines.
cDNA from cells grown in culture media and cells treated with 3% APE for 24 hr were
used in RT-PCR analysis. *= p < 0.05, **=p <0.01 in a paired Student’s T-test
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Figure 3.1b: mRNA expression of IL-1 and IL-6 is higher in IMR90 senescent
cells (p>25) cultured in 21% O2.
cDNA from both presenescent (p<15) and senescent cells (p>25) grown in 3 % O2 and
21% O2 were used in RT-PCR analysis.*Data provided by Donnie McCarthy in order to
confirm that the senescent cell conditioned media from cells have acquired the SASP.
After my colleague confirmed the upregulation of characteristic SASP factors in
senescent IMR90 cells in comparison to the presenescent cultures (Fig. 3.1b), I aimed to
determine if and how the presence of these factors (released into conditioned media) affect the
invasive capabilities of MDA-MB231 metastatic breast cancer cells. Using the in vitro Matrigel
invasion assay as a representative model for chemoinvasion through a basement membrane,
conditioned media cultured from presenescent (passage <15) and senescent (passage >25) cells
were used as the chemoattractants for the cancer cells. The cells in the top of the invasion
chamber were allowed to invade through the matrix for 24 hr and the number of cells migrating
through was observed after DAPI staining. Figure 3.2a and Figure 3.2b depict that more MDAMB231 cells migrated through the chamber with media derived from senescent cells. This
indicates that invasion of cancer cells is enhanced by the presence of inflammatory cytokines and
interleukins, which are characteristic of the SASP that aging cells acquire.

3.2 In vitro Matrigel Invasion Assay
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Figure 3.2a: DAPI stained MDA-MB231 cells.
Media for invasion assay chemoattractant was obtained from IMR-90 presenescent cells,
passage #<15, (right) and senescent cells, passage #>25, (left).

Figure 3.2b: Number of cells that migrated through the Matrigel membrane after a 24
hr incubation at 37C, 5% CO2.
Conditioned media from IMR90 senescent cells enhanced invasion through the membrane.
**= p < 0.01 in a paired Student's T-test
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3.3 Wound Healing Assays

i. No treatment (CM) before

ii. No treatment (CM) after 18 hr

iii. 3% APE before

iv. 3% APE after 18 hr

Figure 3.3a: Wound distances before and after 18 hr treatment of MDA-MB-231
cells with 0% APE, culture media (CM) and 3% APE.
Without treatment of APE, or CM alone cancer cells migrated to close the induced wound,
while treatment with 3% APE significantly inhibited cancer cell migration to close the
wound. Statistical analysis using Tukey’s T-test. *Arrows indicate distances measured
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Figure 3.3b: Percentage (%) of wound closure relative to no treatment of MDAMB 231 cells after 18 hr treatment with different concentrations of APE.
Higher concentrations of APE is correlated with less wound closure or less migration by
the cancer cells **= p < 0.01 in a paired Student's T-test
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i. CMV No treatment (CM) before

iii. CMV 3% APE before

i. CMV No treatment (CM) after 18 hr

iv. CMV 3% APE after 18 hr

v. Sod2 No treatment (CM) before vi. Sod2 No treatment (CM) after 18 hr
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vii. Sod2 3% APE before

ix. Sod2 3% APE after 18 hr

x. Sodcat No treatment (CM) before xi. Sodcat No treatment (CM) after 18 hr

xii. Sodcat 3% APE before

xiii. Sodcat 3% APE after 18 hr

Figure 3.3c: Wound distances before and after 18 hr treatment of CMV, Sod2, and
Sodcat cells with 0 % APE, culture media (CM) and 3% APE.
In all three cell lines treatment with APE promoted cancer cell migration to close the
induced wound, while 3% APE treatment significantly inhibited migration to close the
wound.
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Figure 3.3d: Percentage (%) of wound closure of Sod2 and Sodcat cells relative to
CMV migration after 18 hr treatment with different concentrations of APE.
Higher concentrations of APE treatment combined with increased Sod2 activity is
correlated with a smaller change in distance or less migration by the Sod2 cells
compared to the CMV and Sodcat cell lines, ***= p< 0.001 in a one-way ANOVA test.

It has been determined that ECM degradation, leading to enhanced invasion and
metastasis of MDA-MB231 cells is a redox-dependent process driven by the SASP, and my aim
was to see if a natural antioxidant, apple peel extract (APE), could alter the migratory potential
of various cell types. Wound healing assays are an in vitro method of measuring the change in
distance of cell migration or percentage of wound closure. By scratching a cell monolayer of the
different cell populations (MDA-MB231, CMV, Sod2, and Sodcat) and capturing images at the
beginning and 18 hr after treatment both with and without 3% APE, I calculated the percentage
of wound closure from the measured distances. It was observed that wound healing is also redoxdependent, similar to other cell-matrix and cell-cell interactions.
It is evident from Figure 3.3a that 18 hr treatment with 3% APE inhibited the MDAMB231 cells from healing the wound. Without treatment with APE (Figure 3.3a i and ii) the cells
migrated to close the wound almost entirely, while the 3% treated cells migrated only a small
distance (Figure 3.3a iii and iv). We also found there to be an inverse relationship between the
concentration of APE and the distance the cells migrated. Figure 3.3b shows that as the
concentration of APE increased (no treatment (0%), 0.3%, 1%, 3%) the relative distance the
MDA-MB231 cells moved to close the wound decreased. Therefore, as the antioxidant potential
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of our treatment increased the less migratory capacity these metastatic breast cancer cells
exhibited.
This is also the same trend that I observed in the HT1080-derived CMV, Sod2, and
Sodcat cell lines, where 18 hr treatment with 3% APE inhibited all three cell lines from closing
the wound, producing the smallest change in the induced wound distance. Figure 3.3c i-xiv show
the images of both 0% and 3% APE before and after 18 hr treatment for CMV, Sod2, and Sodcat
cells respectively. I have used the CMV cells as a standard in which to compare the migration of
the Sod2 and Sodcat cells, and Figure 3.3d shows this change relative to the observed CMV
change in distance. I infer that the overexpression of Sod2, and thus MMP-1, in the Sod2 cell
line enabled these cells to migrate the most and nearly close the wound when only culture media
was used as a treatment. The Sod2 cells also exhibited the largest change relative to the CMV
cells in the 3% APE treatment, indicating that this natural antioxidant inhibited the migratory
capacity driven by ROS in the Sod2 cells. This combinatory effect of the treatment with APE
and the overexpression of Sod2 further illustrates how the migration of HT1080 fibrosarcomas,
and as previously noted, metstatic breast cancer cells (MDA-MB231), is a redox-dependent
process. In particular, the ability of Sod2 to augment MMP-1 and other essential proteins used in
the processes of ECM degradation, invasion, and metastasis prompts future research studies
aimed at determining how antioxidants can be used as a therapy to control the cellular redox state
and the deleterious effects of the above cellular processes.
After demonstrating that APE treatment inhibited the migration of both MDA-MB231
and HT1080-engineered cell lines, I sought to determine if this inhibition was caused by APE
acting as an antiproliferative treatment. Figure 3.4 shows there was porliferation by untreated
cells as indicidated by more groth from the initial growth. Alternately, higher concentrations of
APE treatment led to more inhibition growth of the MDA-MB231 cells and it was observed that
with 3 % APE there was about 20% cell death.

3.4 Cytoxicity Assay
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Figure 3.4: Percentage (%) of MDA-MB231 cell growth after 24 hr treatment
with different concentrations of APE.
APE-untreated cells had an increase in growth while higher concentrations of APE
correlated with an inhibition of growth. *= p< 0.05 in a one-way ANOVA test.
DISCUSSION
Many people have heard the saying “an apple a day keeps the doctor away”, but
according to a 2009 study by the Centers for Disease Control and Prevention only 33% of adults
in the United States adults consume the recommended number of servings of fruits (3) per day.
In addition, the potential health benefits that apples provide is concentrated in the apple peels, a
fibrous complex rich in polyphenolic antioxidants that is often discarded by consumers. In an
effort to assess the effects of antioxidants on the redox-dependent invasion and migration of
cancer cells and fibroblasts, apple peel extract (APE) treatment was performed. I aimed to also
confirm that APE has antiproliferative effects on cancer cells, and more specifically on MDAMB231 metastatic breast cancer cells. Although the mechanisms by which APE acts an
antiproliferative therapy are unknown, I speculate that the complex interactions of previously
classified antioxidants found in APE induce its inhibitory effects (12).
I here demonstrate that both the invasive capacities and migratory actions of breast and
lung cancer cell lines are redox-dependent mechanisms that can be inhibited by APE. In addition,
we have demonstrated that the up-regulation of several inflammatory molecules, such as IL-1
and IL-6, in senescent cells is characteristic of the SASP and this induces migration and further
EMT of MDA-MB231 cells. Treatment with APE was effective at inhibiting migration during
the wound healing assays in all cells lines of interest (MDA-MB231, CMV, Sod2, Sodcat) and
when cells were treated with 3% APE this lead to an almost complete inhibition of migration, as
indicated by the minimal % of wound closure. It is important to note that because there was
about small level of cytotoxicity caused in the MDA-MB231 cell line with 3% APE treatment,
the minimal wound closure observed may be affected by this cytotoxicity. However, I speculate
that at non-toxic concentrations treatment with APE will also be effective at inhibiting the SASPchemotactic invasion of MDA-MB231 cells because of the similar mechanisms of cell motility.
Through my freeze-dried method of extracting APE from Organic Gala apples I have preserved
the inhibitory effects of APE and thus accomplished a critical step in the future utilization of
APE or its derivatives as a therapeutic therapy. In the future, principal compound analysis,
including phenolic profiles and antioxidant property determination must be performed to gain a
deeper understanding of the mechanisms by which our freeze-dry APE works to inhibit invasion,
migration, and proliferation.
Further studies will be aimed at confirming that APE can be used as a potential drug
therapy for inhibiting growth of cancer cell lines as observed in the cytotoxicity assay of the 24
hr treatment of MDA-MB231 cells with APE. In addition, it will be important to determine the
concentration of APE treatment that does not inhibit proliferation, but does block MMP-1
production. This will help determine if APE may be a useful treatment for delaying ageassociated diseases that are driven by the SASP and increasing longevity. Since it has been
demonstrated that senescent cells acquire a particularly deleterious phenotype that enhances the
migration of breast cancer cells, it is important to find natural mechanisms to delay or prevent
the SASP and its resulting effects. It is widely known that the risk of developing most cancers
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increases as we age, partly because our body's senescent cells acquire the SASP. In the future,
APE treatment may be used to prevent ROS from accumulating and subsequently activating
proteins responsible for ECM degradation and EMT, and therefore, in vivo studies will be aimed
at further understanding APE and its inhibitory effects.
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